PersonGen BioTherapeutics’ TAA06 Receives Clinical Trial Approval for B7-H3 CAR-T Therapy
The Center for Drug Evaluation (CDE) website indicates that PersonGen BioTherapeutics (Suzhou) Co., Ltd’s TAA06,...
The Center for Drug Evaluation (CDE) website indicates that PersonGen BioTherapeutics (Suzhou) Co., Ltd’s TAA06,...
The Center for Drug Evaluation (CDE) website indicates that Swedish Orphan Biovitrum AB’s (Sobi; BMV:...
The National Health Commission (NHC) has released the “Technical Guidelines for Comprehensive Clinical Evaluation of...
China’s Walvax Biotechnology Co., Ltd (SHE: 300142) has announced the decision to terminate a clinical...
The National Healthcare Security Administration (NHSA) has formulated and released draft proposals for rules covering...
Germany-based Bayer (ETR: BAYN) has announced a voluntary recall of a specific lot of its...